Search by Drug Name or NDC
NDC 60687-0651-21 Mucinex DM 30; 600 mg/1; mg/1 Details
Mucinex DM 30; 600 mg/1; mg/1
Mucinex DM is a ORAL TABLET, EXTENDED RELEASE in the HUMAN OTC DRUG category. It is labeled and distributed by American Health Packaging. The primary component is DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN.
MedlinePlus Drug Summary
Dextromethorphan is used to temporarily relieve cough caused by the common cold, the flu, or other conditions. Dextromethorphan will relieve a cough but will not treat the cause of the cough or speed recovery. Dextromethorphan is in a class of medications called antitussives. It works by decreasing activity in the part of the brain that causes coughing.
Related Packages: 60687-0651-21Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Dextromethorphan
Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.
Related Packages: 60687-0651-21Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Guaifenesin
Product Information
NDC | 60687-0651 |
---|---|
Product ID | 60687-651_025765c9-619a-7e54-e063-6394a90afde3 |
Associated GPIs | |
GCN Sequence Number | 012074 |
GCN Sequence Number Description | guaifenesin/dextromethorphan TAB ER 12H 600MG-30MG ORAL |
HIC3 | B3T |
HIC3 Description | NON-OPIOID ANTITUSSIVE AND EXPECTORANT COMBINATION |
GCN | 53550 |
HICL Sequence Number | 000223 |
HICL Sequence Number Description | GUAIFENESIN/DEXTROMETHORPHAN HBR |
Brand/Generic | Brand |
Proprietary Name | Mucinex DM |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Guaifenesin and Dextromethorphan Hydrobromide |
Product Type | HUMAN OTC DRUG |
Dosage Form | TABLET, EXTENDED RELEASE |
Route | ORAL |
Active Ingredient Strength | 30; 600 |
Active Ingredient Units | mg/1; mg/1 |
Substance Name | DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN |
Labeler Name | American Health Packaging |
Pharmaceutical Class | Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Ant |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA021620 |
Listing Certified Through | n/a |
Package
NDC 60687-0651-21 (60687065121)
NDC Package Code | 60687-651-21 |
---|---|
Billing NDC | 60687065121 |
Package | 30 BLISTER PACK in 1 CARTON (60687-651-21) / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (60687-651-11) |
Marketing Start Date | 2022-07-14 |
NDC Exclude Flag | N |
Pricing Information | |
Price Per Unit | 0.60811 |
Pricing Unit | EA |
Effective Date | 2023-12-20 |
NDC Description | MUCINEX DM ER 600-30 MG TABLET |
Pharmacy Type Indicator | C/I |
OTC | Y |
Explanation Code | 2 |
Classification for Rate Setting | B |
As of Date | 2024-02-21 |